Immune-cell source in patient-derived tumor organoid co-cultures: Methodological choices and clinical interpretation in precision immuno-oncology
World Journal of Clinical Oncology · 29.10.2026
DOI: 10.5306/wjco.125850 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Clinical Oncology, online erschienen am 29.10.2026. Verfasst von Yi-Rong Wang und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, Y., Zhang, Y., Yang, S., Zhang, T., & Lu, Y. (2026). Immune-cell source in patient-derived tumor organoid co-cultures: Methodological choices and clinical interpretation in precision immuno-oncology. World Journal of Clinical Oncology. https://doi.org/10.5306/wjco.125850
Vancouver
Wang Y, Zhang Y, Yang S, Zhang T, Lu Y. Immune-cell source in patient-derived tumor organoid co-cultures: Methodological choices and clinical interpretation in precision immuno-oncology. World Journal of Clinical Oncology. 2026. doi:10.5306/wjco.125850
BibTeX
@article{Wang2026,
author = {Wang, Yi-Rong and Zhang, Ye and Yang, Shi-Qin and Zhang, Ting-Ting and Lu, Yao-Qi},
title = {Immune-cell source in patient-derived tumor organoid co-cultures: Methodological choices and clinical interpretation in precision immuno-oncology},
journal = {World Journal of Clinical Oncology},
year = {2026},
doi = {10.5306/wjco.125850}
}
EUVIMED